Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2025-12-24 @ 4:53 PM
NCT ID:
NCT05382650
Eligibility Criteria:
Inclusion Criteria
1. Received HRIG 300 IU/mL for rabies PEP during an ED encounter visit
2. Aged ≤17 years
Exclusion Criteria
1. HRIG 300 IU/mL dose given is \<18 IU/kg or \>22 IU/kg
2. Patient is admitted or transferred to a hospital from the ED for further management of injuries related to the animal exposure
3. Patient has a history of rabies vaccine or rabies immune globulin administration
4. Legally authorized representative (parent) does not speak English if patient is \<7 years old
5. Legally authorized representative (parent) or patient does not speak English if patient is 7 to 17 years old
6. Inability to obtain consent
1. More than 3 days passed since HRIG 300 IU/mL administration prior to screen
2. Unable to contact legally authorized representative (parent) and/or patient within 3 days of HRIG 300 IU/mL administration
3. Legally authorized representative (parent) and/or patient declined participation
7. Administration sites for HRIG are unknown
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT05382650
Study Brief:
Protocol Section:
NCT05382650